Zennaro M C, Borensztein P, Jeunemaitre X, Armanini D, Soubrier F
INSERM U-36, Collège de France, Paris.
J Clin Endocrinol Metab. 1994 Jul;79(1):32-8. doi: 10.1210/jcem.79.1.8027248.
We have studied the molecular structure of the mineralocorticoid receptor (MR) complementary DNA (cDNA) in a kindred affected by pseudohypoaldosteronism (PHA). In this family, the clinical symptoms included salt wasting and failure to thrive, accompanied by high urinary levels of sodium despite hyponatremia, hyperkalemia and metabolic acidosis, elevation of PRA, and high plasma aldosterone levels. The patients were resistant to mineralocorticoid administration, but their symptoms ameliorated after a period of sodium supplementation, which was discontinued in older patients. Binding studies performed on mononuclear leukocytes of the members of the family have shown the absence of MR in two siblings and a marked reduction in another sibling of the father, suggesting either the absence of MR or a defect of the ligand-binding domain of the MR in these patients. Southern analysis of patient's DNA did not show any major rearrangement of the MR gene. To search for point mutations in the cDNA of the MR, we performed amplification of the MR cDNA by the polymerase chain reaction and direct sequencing of amplified products. No mutation was found in the entire coding sequence of the MR in patients affected by PHA. Although these results do not exclude a molecular abnormality present on the MR gene, they indicate that PHA in this family is not related to a modification of the MR primary structure.
我们研究了一个受假性醛固酮增多症(PHA)影响的家族中盐皮质激素受体(MR)互补DNA(cDNA)的分子结构。在这个家族中,临床症状包括失盐和生长发育不良,尽管存在低钠血症、高钾血症和代谢性酸中毒,但尿钠水平仍很高,血浆肾素活性(PRA)升高,血浆醛固酮水平也很高。患者对盐皮质激素治疗有抵抗,但在补充一段时间钠后症状有所改善,老年患者则停止补充。对该家族成员的单核白细胞进行的结合研究表明,两名同胞中不存在MR,父亲的另一名同胞中MR明显减少,这表明这些患者要么不存在MR,要么MR的配体结合域存在缺陷。对患者DNA的Southern分析未显示MR基因有任何重大重排。为了寻找MR cDNA中的点突变,我们通过聚合酶链反应对MR cDNA进行扩增,并对扩增产物进行直接测序。在受PHA影响的患者中,未在MR的整个编码序列中发现突变。虽然这些结果不排除MR基因存在分子异常,但它们表明该家族中的PHA与MR一级结构的改变无关。